Summary
ViroXis Corporation (ViroXis), a subsidiary of TFS Corporation Limited is a biopharmaceutical company that develops and commercializes botanical pharmaceuticals, which are derived from sandalwood oil. The company’s products include EISO ointment and EISO cream. Its products are used in the treatment of common warts in children and adults, and molluscum contagiosum. ViroXis also develops drugs to treat drug-resistant infections and cancer. The company also offers green tea extract for treatment of genital warts that is known as Veregen. It markets its products through its distributors. ViroXis is headquartered in San Antonio, Texas, the US.
ViroXis Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
ViroXis Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
ViroXis Corporation, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
ViroXis Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
ViroXis Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
ViroXis Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
ViroXis Corporation, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
ViroXis Raises US$7.8 Million In Series B Financing 10
Viroxis Raises US$0.25 Million In Venture Financing 11
Licensing Agreements 12
ViroXis Enters Into Licensing Agreement With Global Pharmaceutical Company To Commercialize OTC Dermatology Product 12
Acquisition 13
TFS Acquires ViroXis 13
ViroXis Corporation - Key Competitors 15
Key Employees 16
Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18
List of Tables
ViroXis Corporation, Pharmaceuticals & Healthcare, Key Facts 1
ViroXis Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
ViroXis Corporation, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
ViroXis Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
ViroXis Corporation, Deals By Therapy Area, 2010 to YTD 2016 8
ViroXis Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
ViroXis Raises US$7.8 Million In Series B Financing 10
Viroxis Raises US$0.25 Million In Venture Financing 11
ViroXis Enters Into Licensing Agreement With Global Pharmaceutical Company To Commercialize OTC Dermatology Product 12
TFS Acquires ViroXis 13
ViroXis Corporation, Key Competitors 15
ViroXis Corporation, Key Employees 16
List of Figures
ViroXis Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
ViroXis Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
ViroXis Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
ViroXis Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
ViroXis Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
ViroXis Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
ViroXis Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
ViroXis Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8